文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肿瘤相关巨噬细胞在非小细胞肺癌中的临床意义及潜在治疗靶点

The clinical significance and potential therapeutic target of tumor-associated macrophage in non-small cell lung cancer.

作者信息

Sun Jiazheng, Zhou Sirui, Sun Yalu, Zeng Yulan

机构信息

Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Affiliated Hospital of Jining Medical University, Jining, China.

出版信息

Front Med (Lausanne). 2025 Apr 30;12:1541104. doi: 10.3389/fmed.2025.1541104. eCollection 2025.


DOI:10.3389/fmed.2025.1541104
PMID:40370720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12076932/
Abstract

One of the leading causes of cancer-related mortality globally is non-small cell lung cancer (NSCLC). It has become a significant public health concern due to its rising incidence rate and fatality. Tumor-associated macrophage (TAM) is important in the tumor microenvironment (TME) of NSCLC because they have an impact on the development, metastasis, and incidence of tumors. As a crucial element of the TME, TAM contributes to tumor immune evasion, facilitates tumor proliferation and metastasis, and modulates tumor angiogenesis, immunosuppression, and treatment resistance through the secretion of diverse cytokines, chemokines, and growth factors. Consequently, TAM assumes a multifaceted and intricate function in the onset, progression, and therapeutic response of NSCLC, serving as a crucial focal point for comprehending the tumor microenvironment and formulating novel therapeutic methods. The study aims to review the biological properties and potential processes of TAM in NSCLC, investigate its involvement in the clinical of NSCLC patients, and discuss its potential as a therapeutic target.

摘要

全球与癌症相关的死亡的主要原因之一是非小细胞肺癌(NSCLC)。由于其发病率和死亡率不断上升,它已成为一个重大的公共卫生问题。肿瘤相关巨噬细胞(TAM)在NSCLC的肿瘤微环境(TME)中很重要,因为它们对肿瘤的发展、转移和发生有影响。作为TME的关键要素,TAM通过分泌多种细胞因子、趋化因子和生长因子,促进肿瘤免疫逃逸,推动肿瘤增殖和转移,并调节肿瘤血管生成、免疫抑制和治疗抗性。因此,TAM在NSCLC的发生、发展和治疗反应中发挥着多方面且复杂的作用,是理解肿瘤微环境和制定新治疗方法的关键焦点。该研究旨在综述TAM在NSCLC中的生物学特性和潜在过程,研究其在NSCLC患者临床中的参与情况,并讨论其作为治疗靶点的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb4/12076932/98c49c451139/fmed-12-1541104-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb4/12076932/98c49c451139/fmed-12-1541104-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb4/12076932/98c49c451139/fmed-12-1541104-g001.jpg

相似文献

[1]
The clinical significance and potential therapeutic target of tumor-associated macrophage in non-small cell lung cancer.

Front Med (Lausanne). 2025-4-30

[2]
Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects.

J Immunother Cancer. 2022-7

[3]
ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.

Theranostics. 2021

[4]
Choline metabolism reprogramming mediates an immunosuppressive microenvironment in non-small cell lung cancer (NSCLC) by promoting tumor-associated macrophage functional polarization and endothelial cell proliferation.

J Transl Med. 2024-5-10

[5]
Comprehensive Integrative Analysis Reveals the Association of with Macrophage Infiltration and Polarization in Lung Cancer Microenvironment.

Cells. 2021-8-14

[6]
Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer.

Cancer Immunol Immunother. 2022-10

[7]
ITGB4/GNB5 axis promotes M2 macrophage reprogramming in NSCLC metastasis.

Int Immunopharmacol. 2025-1-10

[8]
Effects of IFN-γ on the immunological microenvironment and TAM polarity in stage IA non-small cell lung cancer and its mechanisms.

BMC Pulm Med. 2024-1-22

[9]
Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk.

Front Oncol. 2020-3-11

[10]
CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells.

Front Immunol. 2020

本文引用的文献

[1]
P2X7 receptor in macrophage polarization and its implications in neuroblastoma tumor behavior.

Purinergic Signal. 2025-2

[2]
Ultrasound-Responsive Nanocarriers Delivering siRNA and FeO Nanoparticles Reprogram Macrophages and Inhibit M2 Polarization for Enhanced NSCLC Immunotherapy.

ACS Appl Mater Interfaces. 2024-10-23

[3]
Research advances on signaling pathways regulating the polarization of tumor-associated macrophages in lung cancer microenvironment.

Front Immunol. 2024

[4]
New promises and challenges in the treatment of advanced non-small-cell lung cancer.

Lancet. 2024-8-24

[5]
The multifaceted mechanisms of Dihydrotanshinone I in the treatment of tumors.

Biomed Pharmacother. 2024-6

[6]
IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma.

J Exp Clin Cancer Res. 2024-2-29

[7]
Polyphyllin VII induces CTC anoikis to inhibit lung cancer metastasis through EGFR pathway regulation.

Int J Biol Sci. 2023

[8]
Jin-Fu-An decoction manipulation of macrophage polarization via β-catenin (CTNNB1) synergizes with cisplatin in lung cancer.

Biomed Pharmacother. 2023-12

[9]
MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC.

J Thorac Oncol. 2024-3

[10]
Recent advances in liposome-based targeted cancer therapy.

J Liposome Res. 2024-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索